{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:29:18Z","timestamp":1793788158806,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urology.2026.08.031","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:51:02Z","timestamp":1787925062000},"page":"103-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-blockers vs 5-alpha Reductase Inhibitors"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5761-8595","authenticated-orcid":false,"given":"Zaid","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia Abou","family":"Chawareb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed A.M.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samet","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shahait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faysal A.","family":"Yafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.08.031_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.15229","article-title":"Benign prostatic hyperplasia: what do we know?","volume":"127","author":"Devlin","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2026.08.031_bib2","article-title":"Risk factors for benign prostatic hyperplasia: a comprehensive review","volume":"71","author":"Siqueira","year":"2025","journal-title":"Rev Assoc\u00e7\u00e3o M\u00e9dica Bras"},{"key":"10.1016\/j.urology.2026.08.031_bib3","first-page":"61977","article-title":"Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis","volume":"14","author":"Yoosuf","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.urology.2026.08.031_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21037\/tau-22-690","article-title":"5-alpha reductase inhibitors use in prostatic disease and beyond","volume":"12","author":"Chislett","year":"2023","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2026.08.031_bib5","first-page":"475","article-title":"Beyond the prostate: a visionary study on ocular impacts of benign prostatic hyperplasia drugs","volume":"41","author":"Khan","year":"2025","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.urology.2026.08.031_bib6","article-title":"The association between 5\u03b1-reductase inhibitors and the presence of subsequent dry eye disease in androgenetic alopecia: a TriNetX database study","volume":"17","author":"Lee","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.urology.2026.08.031_bib7","article-title":"Editorial: advances in ocular surface disease","volume":"11","author":"Qi","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.urology.2026.08.031_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.18240\/ijo.2021.06.18","article-title":"Androgen and meibomian gland dysfunction: from basic molecular biology to clinical applications","volume":"14","author":"Wang","year":"2021","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.urology.2026.08.031_bib9","article-title":"Systemic medications and their ocular side effects","volume":"16","author":"Al-Namaeh","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.urology.2026.08.031_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.preteyeres.2009.04.003","article-title":"Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases","volume":"28","author":"Dartt","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.urology.2026.08.031_bib11","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/s41467-025-60476-z","article-title":"A gatekeeper sympathetic control of lacrimal tear secretion and dry eye onset through the NA-Adra1a-Ucp2 pathway","volume":"16","author":"Qu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.urology.2026.08.031_bib12","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.3390\/ijms26083833","article-title":"Sex differences in the lacrimal gland: implications for dry eye disease","volume":"26","author":"Ka\u0161telan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urology.2026.08.031_bib13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4103\/IJO.IJO_2887_22","article-title":"Hormones and dry eye disease","volume":"71","author":"Gorimanipalli","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.urology.2026.08.031_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1307682","article-title":"Inflammation mechanism and anti-inflammatory therapy of dry eye","volume":"11","author":"Chu","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.urology.2026.08.031_bib15","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.3390\/ijms24065609","article-title":"Expression of androgen and estrogen receptors in the human lacrimal gland","volume":"24","author":"Hat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urology.2026.08.031_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pcd.2020.01.011","article-title":"Dry eyes in patients with diabetes mellitus","volume":"15","author":"De Freitas","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.urology.2026.08.031_bib17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4103\/IJO.IJO_2770_22","article-title":"Study of dry eye disease in type 2 diabetes mellitus and its association with diabetic retinopathy in Western India","volume":"71","author":"Mansuri","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.urology.2026.08.031_bib18","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/medicina60091458","article-title":"Epidemiology and risk factors of dry eye disease: considerations for clinical management","volume":"60","author":"Britten-Jones","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/j.urology.2026.08.031_bib19","article-title":"Dry eye disease: an overview of its risk factors, diagnosis, and prevalence by age, sex, and race","volume":"16","author":"Deo","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.urology.2026.08.031_bib20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaophthalmol.2022.4394","article-title":"Prevalence and incidence of dry eye and meibomian gland dysfunction in the United States: a systematic review and meta-analysis","volume":"140","author":"McCann","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.urology.2026.08.031_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1542-0124(12)70177-5","article-title":"The aging lacrimal gland: changes in structure and function","volume":"6","author":"Rocha","year":"2008","journal-title":"Ocul Surf"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952600542X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952600542X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:03:41Z","timestamp":1793786621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952600542X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"alternative-id":["S009042952600542X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.08.031","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-blockers vs 5-alpha Reductase Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}